Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    MYL-HER-1002
Previous Study | Return to List | Next Study

Phase 1 Study of Trastuzumab Administered as a Single Intravenous Infusion

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02594761
Recruitment Status : Completed
First Posted : November 3, 2015
Last Update Posted : November 3, 2015
Sponsor:
Collaborator:
Mylan GmbH
Information provided by (Responsible Party):
Mylan Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : February 2014
Actual Study Completion Date : February 2014